Patient guides by country

Patients from around the world frequently find that advanced regenerative treatments, specifically high-dose Umbilical Cord Mesenchymal Stem Cell (UC-MSC) therapies, are restricted or unavailable in their home countries. Regulatory frameworks in many regions often limit the application of these biologics to specific clinical trials or narrow indications, leaving those with chronic degenerative conditions or complex autoimmune needs with few options beyond conventional symptom management.

Thailand has established a robust regulatory framework that allows for the responsible delivery of advanced regenerative medicine. This environment enables clinical teams to utilise sophisticated cell expansion protocols and delivery methods that meet international safety standards while providing access to therapies that remain years away from general availability in other jurisdictions. The Thai medical infrastructure is recognised globally for its high standards of care and commitment to medical innovation.

Chiang Mai has emerged as a premium medical destination, offering a serene environment conducive to recovery and wellness. Boston Health Longevity operates within this clinical infrastructure, providing international patients with access to state-of-the-art facilities and a dedicated team of specialists. Our approach combines advanced science with personalised patient care, ensuring that every individual receives a comprehensive assessment and a treatment plan tailored to their specific medical requirements.